Inhibition of cell migration with synthetic peptides
Abstract
A method of inhibiting the invasion cells, particularly malignant cells through an extracellular membrane by contacting the membrane-cell interface with synthetic Arg-Gly-Asp-containing peptides. In one embodiment, the invention provides peptides containing the amino acid sequence Arg-Gly-Asp-Thr, more specifically Gly-Arg-Gly-Asp-Thr-Pro, which inhibits the attachment of cells to type I collagen in addition to fibronectin and vitronectin, and a method of inhibiting the attachment of cells to type I collagen. The invention further provides an assay for quantitating the invasive quality of cells by determining the amount of such peptides necessary to prevent the cells from penetrating an extracellular membrane, such as an amniotic membrane, in vitro.

Term
Term ended
Projected expiry passed 25 February 2009, 17.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0275748B1 | Cites | European Patent Office (EPO) | XP | Search report |
34 members in 8 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 166530 | United States of America | – | |
| 16653088 | United States of America | A | |
| 166530 | – | – | – |
| US19880166530 | – | – | – |
Members34
| Document | Office | Kind | |
|---|---|---|---|
| WO8400540A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP0114887A1 | European Patent Office (EPO) | A1 | |
| JPS59501548A | Japan | A | |
| US4517686A | United States of America | A | |
| US4578079A | United States of America | A | |
| US4589881A | United States of America | A | |
| US4614517A | United States of America | A | |
| EP0114887A4 | European Patent Office (EPO) | A4 | |
| US4661111A | United States of America | A | |
| US4792525A | United States of America | A | |
| EP0332912A2 | European Patent Office (EPO) | A2 | |
| EP0332912A3This record | European Patent Office (EPO) | A3 | |
| JPH024716A | Japan | A | |
| EP0114887B1 | European Patent Office (EPO) | B1 | |
| AT58740T | Austria | T | |
| DE3382031D1 | Germany | D1 | |
| US5041380A | United States of America | A | |
| CA1296274C | Canada | C | |
| CA1324954C | Canada | C | |
| JPH0631316B2 | Japan | B2 | |
| JPH06293799A | Japan | A | |
| EP0332912B1 | European Patent Office (EPO) | B1 | |
| AT121421T | Austria | T | |
| DE68922234D1 | Germany | D1 | |
| ES2073414T3 | Spain | T3 | |
| DE68922234T2 | Germany | T2 | |
| US5547936A | United States of America | A | |
| JPH08332097A | Japan | A | |
| US5695997A | United States of America | A | |
| JP2744902B2 | Japan | B2 | |
| US5916875A | United States of America | A | |
| US5994501A | United States of America | A | |
| US6180610B1 | United States of America | B1 | |
| US2003143733A1 | United States of America | A1 |
49 legal events, as 6 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Validation in greece3016441FG4A | FG4A | GR | |
| Definitive protectionFG2A | FG2A | ES | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0332912
- Publication, DOCDB
- 0332912
- Publication, EPODOC
- EP0332912
- Application
- 89103359
- Application, DOCDB
- 89103359
- Application, EPODOC
- EP19890103359
Titles3
- English
- Inhibition of cell migration with synthetic peptides
- German
- Hemmung von Migration von Zellen mit Hilfe von synthetischen Peptiden
- French
- Inhibition de la migration de cellules avec des peptides synthétiques
Classification
- CPC, 2
- C07K14/78
- A61P35/00
- IPC, 7
- C12Q1 02
- A61K38 00
- A61P35 00
- C07K7 06
- C07K14 78
- C12Q1 06
- C12R1 91
Designated states13
- Contracting states, 13
- Austria
- Belgium
- Switzerland
- Germany
- Spain
- France
- United Kingdom
- Greece
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden